To methylate means to attach a small chemical tag, a methyl group, onto a molecule such as DNA, a protein, or RNA. This one-atom addition (a carbon bonded to three hydrogens) is one of the most common chemical modifications in biology, and it plays a central role in controlling which genes are turned on or off, how cells specialize during development, and how organisms respond to aging, diet, and environmental exposures. Though the chemistry is simple, the downstream consequences ripple through nearly every branch of medicine and biology, from cancer research to neuroscience to the emerging field of biological age testing.
How Methylation Controls Gene Activity
The most studied form of methylation happens directly on DNA. Enzymes called DNA methyltransferases attach a methyl group to a cytosine base, one of the four letters of the genetic code. This modification occurs primarily where a cytosine sits next to a guanine, at what are called CpG sites. The effect on gene activity depends on where the methylation lands and how much of it accumulates. Methylation at a gene’s promoter region, the stretch of DNA that acts as an on-switch, tends to silence that gene by physically blocking the molecular machinery that reads it. But methylation elsewhere in or around a gene can sometimes enhance expression rather than suppress it.1Nature / Springer Nature (Europe PMC). Fundamentals of DNA methylation in development
Methylation is not limited to DNA. The proteins that DNA wraps around, called histones, are also methylated at specific amino acid positions. Histone methylation changes the shape of the local chromatin, the tightly coiled DNA-protein complex, making genes in that region more or less accessible to the cell’s reading machinery.2PubMed Central. Histone methylation: a dynamic mark in health, disease and inheritance These histone marks work in concert with DNA methylation, acetylation, phosphorylation, and other chemical modifications to create a layered system of gene control.3Endocrine Reviews. Role of Protein Methylation in Regulation of Transcription The combined effect is sometimes compared to annotations scribbled in the margin of a textbook: the underlying text (DNA sequence) stays the same, but the notes tell the cell which passages to read and which to ignore.
Where the Methyl Group Comes From
The body does not conjure methyl groups from nothing. Almost all biological methylation reactions draw their methyl group from a single molecule called S-adenosylmethionine, or SAM. SAM is produced inside cells from the amino acid methionine, and after donating its methyl group it becomes S-adenosylhomocysteine (SAH), which must be recycled. This cycle, often called one-carbon metabolism, depends on several B vitamins and related nutrients to keep running smoothly.4PubMed Central. Mechanisms and rationales of SAM homeostasis
Folate (vitamin B9) and vitamin B12 are particularly important. Folate feeds into the pathway that regenerates methionine from homocysteine, and B12 serves as a cofactor for that reaction. A large study of over 5,800 people found that higher dietary folate intake was associated with lower methylation levels at dozens of specific DNA regions, suggesting that folate status influences the methylation landscape in measurable ways.5PubMed Central. Association of dietary folate and vitamin B-12 intake with genome-wide DNA methylation in blood Meanwhile, a study in rural African women showed that blood levels of one-carbon nutrients like folate, B6, riboflavin, and betaine fluctuated with the seasons, and the ratio of SAM to SAH shifted accordingly, pointing to a surprisingly direct link between dietary supply and methylation capacity.6The American Journal of Clinical Nutrition. DNA methylation potential: dietary intake and blood concentrations of one-carbon metabolites and cofactors in rural African women
A common genetic variant in the MTHFR gene, which encodes a key enzyme in folate metabolism, has drawn widespread public attention. People who carry the C677T variant produce a less efficient version of the enzyme, which can lead to higher homocysteine levels and has been associated with increased risk for cardiovascular disease and other conditions.7PubMed Central. Methylenetetrahydrofolate (MTHFR), the One-Carbon Cycle, and Cardiovascular Risks Despite widespread claims online, though, a meta-analysis found no clear correlation between MTHFR C677T genotype and global DNA methylation levels, suggesting the link between carrying the variant and having a broadly “undermethylated” genome is overstated.8PubMed. Determining the association between methylenetetrahydrofolate reductase (MTHFR) gene polymorphisms and genomic DNA methylation level: A meta-analysis
Methylation During Embryonic Development
Some of the most dramatic methylation changes happen at the very start of life. After a sperm fertilizes an egg, the two parental genomes undergo massive reprogramming. The methylation patterns established in sperm and egg are largely stripped away and then rebuilt from scratch, and this process is strikingly asymmetric between the paternal and maternal genomes.9PubMed Central. Reprogramming DNA methylation in the mammalian life cycle: building and breaking epigenetic barriers By the early blastocyst stage, when the embryo is roughly 32 to 64 cells, overall methylation levels hit their lowest point before being built back up as cells begin to specialize.10Genes & Development. DNA methylation dynamics during epigenetic reprogramming in the germline and preimplantation embryos
Not everything gets wiped clean, however. Certain genes are “imprinted,” meaning they carry methylation marks that survive reprogramming and ensure only the copy from one parent is active. Whether a particular allele’s effect on a trait depends on it coming from the mother or the father is a hallmark of genomic imprinting.11PubMed Central. Genomic imprinting and parent-of-origin effects on complex traits Disruption of these imprints can cause rare but serious developmental disorders such as Prader-Willi and Angelman syndromes.
Methylation is also central to X-chromosome inactivation, the process by which female mammals silence most genes on one of their two X chromosomes to equalize dosage with males. Research on women carrying a single active X found that inactivation is accompanied by increased methylation at the majority of CpG islands on the silenced X, though a small fraction of islands actually become less methylated.12PubMed Central. DNA methylation profiles of human active and inactive X chromosomes An analysis of over 1,800 female samples found high consistency across tissues: about 62% of gene start sites on the X were subject to inactivation in all 27 tissues examined, while roughly 9% escaped inactivation everywhere, and the rest showed variable behavior between tissues and individuals.13Human Molecular Genetics. Landscape of DNA methylation on the X chromosome reflects CpG density, functional chromatin state and X-chromosome inactivation
Methylation, Aging, and Biological Clocks
As people age, their methylation patterns drift in a characteristic way: overall methylation across the genome gradually decreases, while specific promoter regions gain methylation.14PubMed Central. The role of DNA methylation in aging, rejuvenation, and age-related disease Researchers have exploited this predictability to build “epigenetic clocks,” algorithms that estimate a person’s age from the methylation status of a curated set of CpG sites. These clocks are now recognized as one of the most accurate molecular measures of chronological age.15PubMed Central. DNA methylation aging clocks: challenges and recommendations
More intriguing is the gap between clock-predicted age and actual calendar age. When the clock says you are “older” than your birth certificate, that accelerated epigenetic aging predicts higher mortality risk. A large meta-analysis confirmed that every measure of epigenetic age acceleration tested was an independent predictor of death, even after adjusting for traditional risk factors like smoking and BMI, and the association held across racial and ethnic groups.16PubMed Central. DNA methylation-based measures of biological age: meta-analysis predicting time to death This has made epigenetic clocks a hot tool in longevity research, where investigators use them to test whether interventions like caloric restriction or exercise slow biological aging.
When Methylation Goes Wrong in Cancer
Cancer cells carry a deeply disordered methylation landscape. The same pattern that characterizes aging, global loss of methylation plus targeted gains at specific promoters, is amplified in tumors. Promoter methylation at tumor suppressor genes effectively shuts those genes off, removing a critical brake on cell growth.17PubMed Central. DNA Methylation: An Alternative Pathway to Cancer This silencing of tumor suppressors by promoter CpG island hypermethylation is considered a universal feature of human cancers.18Human Molecular Genetics. Epigenetic gene silencing in cancer: the DNA hypermethylome
Because aberrant methylation marks show up in cell-free DNA that tumors shed into the bloodstream, researchers are developing blood-based tests that read these marks to detect cancer early. One study targeting colorectal and gastric cancers achieved sensitivity around 81 to 83% with specificity around 80 to 82%, demonstrating the promise of methylation profiling as a noninvasive screening tool.19PubMed Central. Cell-free DNA methylation profiles enable early detection of colorectal and gastric cancer Several commercial multi-cancer early detection tests now in development rely on similar methylation-based approaches.
Methylation’s role in cancer has also opened a therapeutic door. Drugs that inhibit DNA methyltransferases can reactivate silenced tumor suppressor genes. Azacitidine and decitabine, two such inhibitors, are already approved for treating acute myeloid leukemia, myelodysplastic syndromes, and chronic myelomonocytic leukemia.20PubMed. Targeting DNA methyltransferases for cancer therapy In practice, these drugs work best in blood cancers and have shown limited effectiveness as single agents in solid tumors. More recent strategies pair them with other treatments: combining a methyltransferase inhibitor with the BCL-2 inhibitor venetoclax, for instance, has become a standard regimen in certain blood cancers.21PubMed Central. DNA methyltransferase inhibitors in oncology: clinical progress, limitations and future directions
Methylation in the Brain
For decades, DNA methylation was thought to be a static mark, laid down during development and then left alone. That assumption started falling apart when researchers found that methylation changes dynamically in the adult brain during learning. In a landmark experiment, fear conditioning in rats triggered rapid methylation changes in the hippocampus: a memory-suppressing gene called PP1 was methylated and silenced, while the synaptic plasticity gene reelin was demethylated and activated. Blocking the enzymes responsible for adding methyl groups prevented the animals from forming new memories.22PubMed. Covalent modification of DNA regulates memory formation
The discovery of Tet enzymes, which oxidize methylated cytosines and effectively erase methyl marks, added another dimension. By removing methylation, Tet enzymes allow genes to be reactivated, making the system bidirectional rather than a one-way silencing switch.23PubMed Central. The role of active DNA demethylation and Tet enzyme function in memory formation and cocaine action These enzymes work through oxidation of the methylated base, and the resulting modified base is either passively diluted during cell division or actively removed by repair pathways.24National Science Review. Oxidative DNA demethylation mediated by Tet enzymes This back-and-forth between methylation and demethylation appears to be essential for the brain’s ability to form lasting memories while remaining flexible enough to learn new information.25PubMed Central. DNA Methylation in Memory Formation: Emerging Insights
Environmental Exposures and Methylation
The methylation landscape is not sealed off from the outside world. Toxic metals such as lead, arsenic, and cadmium are well-documented modifiers of DNA methylation patterns, and the evidence is strongest for exposures during pregnancy. Prenatal exposure to these metals has been linked to altered methylation at specific genomic sites in offspring, raising concerns about long-term health effects programmed before birth.26PubMed Central. Metals exposures and DNA methylation: Current evidence and future directions Stem and progenitor cells appear to be especially vulnerable, because these cells depend on tightly regulated epigenetic reprogramming to function properly.27PubMed. Epigenetic toxicity of heavy metals – implications for embryonic stem cells
Adult exposures matter too. Epidemiological evidence links lead, arsenic, and cadmium to detectable methylation signatures in adult blood, though the health significance of those shifts is still being worked out.28PubMed Central. DNA methylation changes induced by prenatal toxic metal exposure: An overview of epidemiological evidence The broader concern is that environmental exposures may nudge the epigenome toward disease states, a process that would not show up in standard genetic testing because the DNA sequence itself remains unchanged.
Exercise and Diet as Methylation Modulators
If environmental toxins can alter methylation for the worse, lifestyle choices can push it in healthier directions. A single session of vigorous exercise decreases methylation at the promoters of genes involved in energy metabolism in skeletal muscle, with the degree of change tracking the intensity of the workout.29PubMed. Acute exercise remodels promoter methylation in human skeletal muscle Over longer periods, a six-month exercise intervention altered methylation at nearly 18,000 individual CpG sites in human fat tissue, with about a third of the affected gene regions also showing changes in gene expression.30PLOS Genetics. A Six Months Exercise Intervention Influences the Genome-wide DNA Methylation Pattern in Human Adipose Tissue Some of these exercise-induced epigenetic marks have been associated with reduced risk of chronic diseases, though pinning down which specific marks matter most is ongoing work.31PubMed Central. Physical Activity and DNA Methylation in Humans
Nutrition, as discussed earlier in the context of one-carbon metabolism, provides the raw materials for methylation. Animal studies have shown that imbalances in folate and B12 during pregnancy can shift global methylation patterns in both maternal tissues and the next generation.32Scientific Reports. Effect of imbalance in folate and vitamin B12 in maternal/parental diet on global methylation and regulatory miRNAs Whether ordinary dietary variation in well-nourished populations produces meaningful methylation shifts is less certain. The strongest nutritional effects tend to show up in populations with frank deficiencies or during critical developmental windows like pregnancy.
RNA Methylation
DNA is not the only molecule that gets methylated. Messenger RNA, the intermediate between a gene and the protein it encodes, carries its own methylation mark called m6A (N6-methyladenosine). This is the most abundant internal modification on mRNA, and it is installed by a dedicated complex of enzymes and removed by a separate set of erasers. m6A methylation influences nearly every stage of an mRNA’s life: how it is spliced, how quickly it is exported from the nucleus, how efficiently it is translated into protein, and how fast it degrades.33PubMed Central. m6A RNA methylation: from mechanisms to therapeutic potential Specialized “reader” proteins recognize m6A marks and carry out these downstream effects.34Signal Transduction and Targeted Therapy. The role of m6A modification in the biological functions and diseases
The field of RNA modifications, sometimes called epitranscriptomics, is younger than DNA methylation research and is moving fast. Abnormal m6A patterns have been linked to various cancers, neurological conditions, and immune disorders, though therapeutic targeting of RNA methylation is still in early stages compared to the DNA methyltransferase inhibitors already in clinical use.
Methylation in Drug Metabolism
Methylation is not just a regulatory trick for gene control; it is also a detoxification strategy. The body uses methyltransferase enzymes to attach methyl groups to drugs and other foreign compounds, altering their activity and preparing them for elimination. One well-known example involves thiopurine drugs like 6-mercaptopurine, which are used to treat leukemia and inflammatory bowel disease. An enzyme called thiopurine S-methyltransferase (TPMT) methylates these drugs, and people carry different genetic variants that affect how much TPMT enzyme they produce.35PubMed. Methylation pharmacogenetics: catechol O-methyltransferase, thiopurine methyltransferase, and histamine N-methyltransferase
Patients with very low TPMT activity metabolize thiopurines slowly, causing the drug to accumulate to toxic levels. This can lead to severe, sometimes life-threatening suppression of bone marrow. For this reason, it is now recommended that patients be tested for TPMT status before starting thiopurine treatment, so the dose can be adjusted accordingly.36PubMed. Comprehensive study of thiopurine methyltransferase genotype, phenotype, and genotype-phenotype discrepancies in Sweden This is one of the clearest examples of pharmacogenomics in routine clinical practice: a methylation enzyme whose genetic variation directly changes how a drug should be prescribed.
How Bacteria Use Methylation
Methylation is not unique to mammals. Bacteria have used DNA methylation for billions of years, primarily as part of restriction-modification systems that protect against invading viral DNA. The bacterium methylates its own DNA at specific sequences, and any foreign DNA that lacks those marks gets cut apart by restriction enzymes. In many species, these systems appear to have no broader effect on the bacterium’s own gene expression. A study in E. coli found that three distinct restriction-modification systems had no measurable impact on gene expression, virulence, or any of nearly 1,200 growth conditions tested.37Nucleic Acids Research. DNA methylation by three Type I restriction modification systems of Escherichia coli does not influence gene regulation of the host bacterium
In some pathogenic bacteria, however, methylation takes on a more sinister role. Phase-variable restriction-modification systems can randomly switch their methylation patterns on and off, altering the expression of entire sets of genes in a coordinated way. These switches, called phasevarions, let bacteria rapidly change their surface features, helping them dodge the host immune system.38PubMed. Epigenetic Regulation of Virulence and Immunoevasion by Phase-Variable Restriction-Modification Systems in Bacterial Pathogens It is a reminder that the same basic chemistry, adding a methyl group to DNA, has been repurposed by evolution for vastly different ends depending on the organism.
Can Methylation Changes Be Inherited Across Generations?
One of the most debated questions in the field is whether methylation changes caused by environment or experience can be passed from parent to child, and then to grandchild, without any change to the DNA sequence itself. This idea, called transgenerational epigenetic inheritance, has captivated the public imagination. Studies in plants offer solid evidence that it happens. In mammals, the picture is far murkier. The extensive methylation reprogramming that occurs in the embryo, described earlier, erases most parental methylation marks, which would seem to work against transgenerational transmission.39PubMed Central. Reprogramming DNA methylation in the mammalian life cycle: building and breaking epigenetic barriers
The honest summary of the evidence is that while the environment can influence gene expression through methylation and can contribute to disease, the extent to which these methylation changes survive the erasure events of early development and pass to future generations in humans remains unclear. A number of animal studies show intriguing hints, but rigorous demonstration of true transgenerational epigenetic inheritance in humans, as distinct from effects mediated by direct fetal exposure or shared environment, has proven elusive. The concept is real in biology but should not be treated as established fact in human health the way it sometimes appears in popular media.